 |
Disodium clodronate tetrahydrate |
|---|---|
| Trade Name | Bonefos |
| Orphan Indication | Increased bone resorption due to malignancy |
| USA Market Approval | USA |
| USA Designation Date | 1990-03-05 00:00:00 |
| Sponsor | Anthra Pharmaceuticals, Inc.;103 Carnegie Center, Suite 102;Princeton, New Jersey, 08540 |
